Recent events
2025-08-21
Other facts
PRIMARY
Most of HPSP's systems are being exported to the US, Japan, and Taiwan, while its reliance on China is low
2025-08-21
Other facts
PRIMARY
HPSP achieved an operating margin rate of 53.7% in the first half of 2024, making it the highest among top 50 fab equipment makers in South Korea
2025-06-15
Other facts
SECONDARY
Crescendo's 2025 divestiture of its HPSP controlling stake to major US private equity firms (KKR, Carlyle, Blackstone) could trigger CFIUS review due to the strategic nature of semiconductor manufacturing equipment
2025-06-15
Transactions
INFERENTIAL
Korean Fair Trade Commission filing requirements for foreign investment transactions could provide the most detailed public disclosure of HPSP's operations through Crescendo's exit process
2025-06-15
Other facts
SECONDARY
Crescendo's 2025 exit from HPSP represents the first major private equity divestiture of a monopolistic semiconductor equipment supplier during the post-CHIPS Act regulatory environment
2025-01-01
Other facts
PRIMARY
KKR, Carlyle, and Blackstone submitted bids for Crescendo's HPSP stake
2025-01-01
Other facts
PRIMARY
HPSP is often dubbed 'Korea's ASML' and dominates the market for semiconductor annealing equipment
2025-01-01
Transactions
PRIMARY
HPSP's market capitalization reached approximately 3.5 trillion won ($2.4 billion) by 2025
2025-01-01
Other facts
PRIMARY
Crescendo initiated the sale of its 40.9% controlling equity stake in HPSP in 2025
2024-06-15
Transactions
INFERENTIAL
HPSP (Korean semiconductor company) would only generate FEC records if: (1) it established a US-incorporated subsidiary that formed a PAC, (2) US-citizen executives made individual contributions listing HPSP as…
2024-06-15
Other facts
SECONDARY
The inferential claim about SEC subsidiary reporting requirements is technically accurate under Securities Exchange Act Section 12(g) but represents a complete jurisdictional category error when applied to Korean HPSP…
2024-06-15
Transactions
SECONDARY
The research record demonstrates systematic disambiguation failure across 40+ established facts, with no verified information specifically about HPSP the Korean semiconductor company despite it being the stated…
2024-06-15
Other facts
SECONDARY
The inferential claim about USASpending.gov queries for 'HPSP administration support services' pertains exclusively to the DoD Health Professions Scholarship Program and contains no information relevant to HPSP the…
2024-06-15
Transactions
SECONDARY
Proper investigation of HPSP (Korean semiconductor company) requires accessing Korea's DART disclosure system, Korean Intellectual Property Office patent records, and conducting supplier disclosure searches in SEC…
2024-06-15
Other facts
SECONDARY
The inferential claim about individual scholarship award privacy pertains exclusively to the DoD Health Professions Scholarship Program and is jurisdictionally inapplicable to HPSP the Korean semiconductor equipment…
2024-06-15
Transactions
SECONDARY
The research record contains zero verified facts about the stated investigation subject (Korean semiconductor company HPSP) despite 40+ established facts entries—all existing facts address unrelated US entities sharing…
2024-06-15
Transactions
SECONDARY
Proper investigation of Korean HPSP requires pivoting entirely to Korean-language sources: DART disclosure system for corporate filings, KIPO for patent verification, and KRX for trading data—US regulatory databases…
2024-06-15
Transactions
SECONDARY
The inferential claim about parliamentary records is a valid disambiguation note applicable to Western legislative databases but contains zero investigative value for HPSP (KOSDAQ: 403870), as UK Parliament and US…
2024-06-15
Transactions
SECONDARY
The investigation record demonstrates a complete research pivot failure: despite the subject entity being clearly identified as a Korean semiconductor company, 100% of collected evidence pertains to unrelated US…
2024-06-15
Transactions
SECONDARY
Investigation of HPSP (Korean semiconductor company) in European contexts should focus on (1) European Chips Act supply chain discussions, (2) EPO patent filings, and (3) potential EU subsidiary registrations rather…
2024-06-15
Transactions
SECONDARY
The inferential claim about FEC database requirements is procedurally accurate under 52 U.S.C. §30104 but pertains exclusively to HPSP PAC (healthcare union), not the Korean semiconductor company under investigation
2024-06-15
Transactions
SECONDARY
This investigation demonstrates a complete research methodology failure: despite being tasked with investigating Korean HPSP (KOSDAQ: 403870), 100% of FEC-related research focused on an unrelated US healthcare union…
2024-06-15
Other facts
SECONDARY
Proper verification of Korean HPSP requires pivoting to Korea's regulatory systems (DART, FSS, KIPO) rather than continuing to research unrelated US entities sharing the HPSP acronym
2024-06-15
Transactions
SECONDARY
This investigation has produced zero verified facts about its stated subject (Korean semiconductor company HPSP) across 40+ established facts entries, demonstrating complete research methodology breakdown caused by…
2024-06-15
Transactions
SECONDARY
This investigation represents a complete research methodology failure case study, where systematic acronym disambiguation was never implemented despite the Korean semiconductor company being clearly identified as the…
+103 earlier events on the chart
GOBLIN HOUSE
[ Enter Database → ]